JUVE Fundamental Analysis - JUVENTUS FOOTBALL CLUB SPA

Fundamental Rating

Overall JUVE gets a fundamental rating of 1 out of 10. We evaluated JUVE against 48 industry peers in the Entertainment industry. Both the profitability and financial health of JUVE have multiple concerns. JUVE has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year JUVE has reported negative net income.
In the past year JUVE had a positive cash flow from operations.
JUVE had negative earnings in each of the past 5 years.
In multiple years JUVE reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of JUVE (-7.34%) is worse than 66.67% of its industry peers.
JUVE has a worse Return On Equity (-439.14%) than 77.08% of its industry peers.

		Industry Rank	Sector Rank
ROA	-7.34%
ROE	-439.14%
ROIC	N/A

ROA(3y)-17.17%

ROA(5y)-20.44%

ROE(3y)-409.53%

ROE(5y)-798.75%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of JUVE (88.51%) is better than 75.00% of its industry peers.
JUVE's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for JUVE so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	88.51%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.57%

GM growth 5Y0.02%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

JUVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JUVE remains at a similar level compared to 1 year ago.
The number of shares outstanding for JUVE has been reduced compared to 5 years ago.
JUVE has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.64, we must say that JUVE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.64, JUVE perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
JUVE has a Debt/Equity ratio of 21.46. This is a high value indicating a heavy dependency on external financing.
JUVE's Debt to Equity ratio of 21.46 is on the low side compared to the rest of the industry. JUVE is outperformed by 77.08% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	21.46
Debt/FCF	N/A
Altman-Z	0.64

ROIC/WACCN/A

WACC7.34%

2.3 Liquidity

A Current Ratio of 0.47 indicates that JUVE may have some problems paying its short term obligations.
JUVE's Current ratio of 0.47 is on the low side compared to the rest of the industry. JUVE is outperformed by 85.42% of its industry peers.
A Quick Ratio of 0.47 indicates that JUVE may have some problems paying its short term obligations.
JUVE has a Quick ratio of 0.47. This is amonst the worse of the industry: JUVE underperforms 85.42% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.47
Quick Ratio	0.47

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.82% over the past year.
JUVE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.31%.
The Revenue has been growing slightly by 1.84% on average over the past years.

EPS 1Y (TTM)70.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-4.89%

Revenue 1Y (TTM)18.31%

Revenue growth 3Y-0.27%

Revenue growth 5Y1.84%

Sales Q2Q%8.62%

3.2 Future

The Earnings Per Share is expected to decrease by -17.07% on average over the next years. This is quite bad
Based on estimates for the next years, JUVE will show a small growth in Revenue. The Revenue will grow by 2.36% on average per year.

EPS Next Y-44.39%

EPS Next 2Y17.46%

EPS Next 3Y-17.07%

EPS Next 5YN/A

Revenue Next Year-6.09%

Revenue Next 2Y-2.13%

Revenue Next 3Y-0.94%

Revenue Next 5Y2.36%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

JUVE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year JUVE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

JUVE's Enterprise Value to EBITDA is on the same level as the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	41.98

4.3 Compensation for Growth

JUVE's earnings are expected to decrease with -17.07% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y17.46%

EPS Next 3Y-17.07%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

JUVE does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

JUVENTUS FOOTBALL CLUB SPA

BIT:JUVE (1/15/2026, 4:26:55 PM)

2.688

+0.01 (+0.22%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryEntertainment

Earnings (Last)09-26 2025-09-26/amc

Earnings (Next)02-26 2026-02-26

Inst Owners10.01%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap1.12B

Revenue(TTM)439.76M

Net Income(TTM)-58.15M

Analysts45.45

Price Target2.75 (2.31%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-10.5%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-260%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.51%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2.55
P/FCF	N/A
P/OCF	43.66
P/B	84.66
P/tB	N/A
EV/EBITDA	41.98

EPS(TTM)-0.21

EYN/A

EPS(NY)-0.09

Fwd EYN/A

FCF(TTM)-0.47

FCFYN/A

OCF(TTM)0.06

OCFY2.29%

SpS1.05

BVpS0.03

TBVpS-0.88

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.34%
ROE	-439.14%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	88.51%
FCFM	N/A

ROA(3y)-17.17%

ROA(5y)-20.44%

ROE(3y)-409.53%

ROE(5y)-798.75%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.57%

GM growth 5Y0.02%

F-Score6

Asset Turnover0.56

Health

		Industry Rank	Sector Rank
Debt/Equity	21.46
Debt/FCF	N/A
Debt/EBITDA	8.67
Cap/Depr	162.73%
Cap/Sales	50.75%
Interest Coverage	N/A
Cash Conversion	78.39%
Profit Quality	N/A
Current Ratio	0.47
Quick Ratio	0.47
Altman-Z	0.64

F-Score6

WACC7.34%

ROIC/WACCN/A

Cap/Depr(3y)108.07%

Cap/Depr(5y)101.17%

Cap/Sales(3y)37.97%

Cap/Sales(5y)38.64%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)70.82%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-4.89%

EPS Next Y-44.39%

EPS Next 2Y17.46%

EPS Next 3Y-17.07%

EPS Next 5YN/A

Revenue 1Y (TTM)18.31%

Revenue growth 3Y-0.27%

Revenue growth 5Y1.84%

Sales Q2Q%8.62%

Revenue Next Year-6.09%

Revenue Next 2Y-2.13%

Revenue Next 3Y-0.94%

Revenue Next 5Y2.36%

EBIT growth 1Y42.21%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year5602.26%

EBIT Next 3Y302.59%

EBIT Next 5Y135.22%

FCF growth 1Y-31.13%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y155.76%

OCF growth 3YN/A

OCF growth 5YN/A

JUVENTUS FOOTBALL CLUB SPA / JUVE.MI FAQ

What is the fundamental rating for JUVE stock?

ChartMill assigns a fundamental rating of 1 / 10 to JUVE.MI.

What is the valuation status of JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) stock?

ChartMill assigns a valuation rating of 0 / 10 to JUVENTUS FOOTBALL CLUB SPA (JUVE.MI). This can be considered as Overvalued.

How profitable is JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) stock?

JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) has a profitability rating of 1 / 10.

Can you provide the financial health for JUVE stock?

The financial health rating of JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) is 1 / 10.

JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

JUVENTUS FOOTBALL CLUB SPA / JUVE.MI FAQ

What is the fundamental rating for JUVE stock?

What is the valuation status of JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) stock?

How profitable is JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) stock?

Can you provide the financial health for JUVE stock?